The Board of Scientific Counselors of the National Center for Injury Prevention and Control (BSC/NCIPC) has established an Opioid Workgroup (OWG) to provide expert input and observations on a possible update or expansion of the CDC Guideline for Prescribing Opioids for Chronic Pain —United States, 2016.
The Opioid Workgroup will be comprised of 12–20 people. The chair must be an appointed BSC/NCIPC member, and there must be at least one other OWG member who is an appointed member of the BSC/NCIPC. Remaining members will be external experts who can enhance the expertise on the workgroup to assist the group in completing its tasks. A limited number of ad hoc consultants might also be considered to provide additional expert opinions as needed, and participation of representatives from some other federal agencies is anticipated.
In seeking a balance of perspectives among workgroup members, CDC is continuing to work to identify audiences directly affected by the guideline, audiences that would be directly involved with implementing or integrating recommendations into current practice, and audiences qualified to provide representation of a specific discipline or expertise in alignment with the tasks of the workgroup. Perspectives that would support or enhance the workgroup’s capacity to complete tasks include, but are not limited to, those of the following groups:
- Patients and Families
- Pharmacists/ Pharmacologists
- Public health practitioners
- Research scientists
People who wish to be considered for nomination to the workgroup should self-nominate by emailing their current curriculum vitae (CV) and contact information to email@example.com by or before Tuesday, February 4, 2020.
Additional information and resources about the BSC/NCIPC include:
- BSC/NCIPC agenda and minutes for the December 4-5, 2019, meeting
Opioid Workgroup – 2019 webpage featuring Frequently Asked Questions (FAQs).